Cargando…
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
Immune checkpoint blockade is a compelling approach in tumor immunotherapy. Blocking inhibitory pathways in T cells has demonstrated clinical efficacy in different types of cancer and may hold potential to also stimulate innate immune responses. A novel emerging potential target for immune checkpoin...
Autores principales: | Zeller, Tobias, Münnich, Ira A., Windisch, Roland, Hilger, Patricia, Schewe, Denis M., Humpe, Andreas, Kellner, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533923/ https://www.ncbi.nlm.nih.gov/pubmed/37781391 http://dx.doi.org/10.3389/fimmu.2023.1240275 |
Ejemplares similares
-
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
por: Zeller, Tobias, et al.
Publicado: (2022) -
LILRB4, an immune checkpoint on myeloid cells
por: Yang, Ting, et al.
Publicado: (2022) -
NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases
por: Zhang, Yiwen, et al.
Publicado: (2021) -
Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure
por: Hogan, Louise E., et al.
Publicado: (2016) -
Structure and functions of Mer, an innate immune checkpoint
por: Ubil, Eric, et al.
Publicado: (2023)